Home › Companies › Biopharma, Biotechnology, Cosmetic Surgery, Landscaping, Medical, Pharmaceutical, Therapeutics › Glyscend Therapeutics
Glyscend Therapeutics
Glyscend develops a revolutionary approach to treating type 2 diabetes.
Glyscend Therapeutics is a business in biopharma, biotechnology, cosmetic surgery, landscaping, medical, pharmaceutical, therapeutics based in Greater Baltimore-Maryland Area, East Coast, Southern US, founded in 2014.
The company sits in the biopharma, biotechnology, cosmetic surgery, landscaping, medical, pharmaceutical, therapeutics segment, where it competes on its core product or service.
The business is associated with Greater Baltimore-Maryland Area, East Coast, Southern US.
Directory data places it at the Series_A stage.
Recorded headcount: c_00001_00010 employees.
Public records show total funding of about $21.7M.
| Sector | Biopharma, Biotechnology, Cosmetic Surgery, Landscaping, Medical, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | Greater Baltimore-Maryland Area, East Coast, Southern US |
| Country | US |
| Founded | 2014 |
| Employees | c_00001_00010 |
| Stage | series_a |
| Total funding | $21,728,669 |
Website: www.glyscend.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account